A detailed history of M&T Bank Corp transactions in Pfizer Inc stock. As of the latest transaction made, M&T Bank Corp holds 2,693,764 shares of PFE stock, worth $75.4 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
2,693,764
Previous 2,554,198 5.46%
Holding current value
$75.4 Million
Previous $73.5 Million 1.65%
% of portfolio
0.26%
Previous 0.27%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$25.89 - $29.73 $3.61 Million - $4.15 Million
139,566 Added 5.46%
2,693,764 $74.8 Million
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $7.32 Million - $9.51 Million
-280,140 Reduced 9.88%
2,554,198 $73.5 Million
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $2.79 Million - $3.26 Million
-86,968 Reduced 2.98%
2,834,338 $94 Million
Q2 2023

Aug 09, 2023

SELL
$36.12 - $41.79 $1.64 Million - $1.9 Million
-45,455 Reduced 1.53%
2,921,306 $107 Million
Q1 2023

May 11, 2023

SELL
$39.39 - $51.28 $1.24 Million - $1.61 Million
-31,418 Reduced 1.05%
2,966,761 $121 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $105,377 - $137,558
-2,524 Reduced 0.08%
2,998,179 $154 Million
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $87,591 - $114,341
-2,098 Reduced 0.07%
3,000,703 $154 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $2.21 Million - $2.7 Million
50,463 Added 1.71%
3,002,801 $128 Million
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $11.6 Million - $13.7 Million
248,594 Added 9.19%
2,952,338 $144 Million
Q1 2022

May 09, 2022

SELL
$45.75 - $56.69 $2.25 Million - $2.79 Million
-49,146 Reduced 1.79%
2,703,744 $140 Million
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $3.42 Million - $5.07 Million
-82,748 Reduced 2.92%
2,752,890 $163 Million
Q3 2021

Oct 28, 2021

SELL
$39.25 - $50.42 $951,380 - $1.22 Million
-24,239 Reduced 0.85%
2,835,638 $122 Million
Q2 2021

Aug 13, 2021

SELL
$35.91 - $40.68 $5.36 Million - $6.07 Million
-149,162 Reduced 4.96%
2,859,877 $112 Million
Q1 2021

May 06, 2021

SELL
$33.49 - $37.77 $4.75 Million - $5.36 Million
-141,902 Reduced 4.5%
3,009,039 $109 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $2.12 Million - $2.69 Million
-63,271 Reduced 1.97%
3,150,941 $116 Million
Q3 2020

Nov 06, 2020

SELL
$31.75 - $37.25 $10.9 Million - $12.8 Million
-344,052 Reduced 9.67%
3,214,212 $118 Million
Q2 2020

Jul 29, 2020

SELL
$30.12 - $36.54 $2.29 Million - $2.78 Million
-76,048 Reduced 2.09%
3,558,264 $116 Million
Q1 2020

May 14, 2020

SELL
$27.03 - $38.62 $1.72 Million - $2.46 Million
-63,689 Reduced 1.72%
3,634,312 $119 Million
Q4 2019

Feb 07, 2020

SELL
$32.92 - $37.36 $594,140 - $674,273
-18,048 Reduced 0.49%
3,698,001 $145 Million
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $217,650 - $282,228
-6,699 Reduced 0.18%
3,716,049 $134 Million
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $3.01 Million - $3.38 Million
-81,403 Reduced 2.14%
3,722,748 $161 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $1.51 Million - $1.66 Million
-40,310 Reduced 1.05%
3,804,151 $162 Million
Q4 2018

Feb 01, 2019

SELL
$38.47 - $43.86 $2.45 Million - $2.79 Million
-63,638 Reduced 1.63%
3,844,461 $168 Million
Q3 2018

Nov 09, 2018

SELL
$34.47 - $41.81 $2.9 Million - $3.52 Million
-84,118 Reduced 2.11%
3,908,099 $172 Million
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $314,497 - $335,285
9,536 Added 0.24%
3,992,217 $145 Million
Q1 2018

May 04, 2018

SELL
$31.91 - $37.02 $831,223 - $964,333
-26,049 Reduced 0.65%
3,982,681 $141 Million
Q4 2017

Feb 06, 2018

SELL
$33.26 - $35.29 $244,627 - $259,557
-7,355 Reduced 0.18%
4,008,730 $145 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $1.24 Million - $1.36 Million
39,893 Added 1.0%
4,016,085 $143 Million
Q2 2017

Aug 11, 2017

BUY
N/A
3,976,192
3,976,192 $134 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.